News

EvenUp Secures $135M Funding to Transform Personal Injury Law

EvenUp Secures $135M Funding to Transform Personal Injury Law

EvenUp Secures $135 Million in Series D Funding

EvenUp, a frontrunner in AI technology for personal injury cases, has successfully raised $135 million in a Series D funding round led by Bain Capital Ventures. This funding is set to propel their mission to empower personal injury firms with advanced tools enabling smarter work, quicker settlements, and fairer outcomes for clients.

Funding Overview and Expansion Plans

With this latest investment, EvenUp's total funding reaches $235 million, allowing them to enhance their product suite significantly. This latest round stands among the most substantial in the realm of legal AI, reflecting a valuation that exceeds $1 billion for the company. Overall, EvenUp aims to close the justice gap by combining innovative technology and artificial intelligence in personal injury law.

CEO's Vision for Justice

Rami Karabibar, the CEO and co-founder of EvenUp, expressed his passion for addressing the inequalities faced by millions of injury victims. "Our goal is to support personal injury firms in delivering exemplary representation and to help victims receive just compensation quickly and efficiently," he said. The company is dedicated to enhancing its leadership team and investing in talent to sustain its growth.

Innovative Product Suite for Personal Injury Firms

EvenUp’s recent funding will also aid in the enhancement of their product offerings, allowing law firms to navigate the complexities of case management with greater efficiency. Over 1,000 law firms currently rely on EvenUp's solutions, which have helped recover over $1.5 billion in claims. One standout feature is EvenUp's product Demands, which has shown a remarkable 69% success rate compared to traditional demand letters.

Advanced Tools for Case Management

The AI-driven Claims Intelligence Platform™ is designed to assist case managers and attorneys throughout the entire personal injury case lifecycle. This platform is propelled by Piai™, EvenUp's AI model which utilizes vast datasets from numerous injury case studies and medical records.

Key Features to Enhance Performance

  • Case Preparation: This innovative product proactively identifies missing documents, streamlining case preparation and significantly reducing time to settlement.
  • Negotiation Preparation: With the help of AI, this tool equips attorneys with the crucial insights needed during negotiations, enhancing their readiness and response times.
  • Executive Analytics: This feature provides access to invaluable insights and benchmarks, enabling executives to evaluate case performance and make informed decisions to foster growth.
  • Settlement Repository: A critical resource allowing firms to gain insight into past settlements, arming them with data crucial for navigating negotiations efficiently.

Massive Growth and Future Outlook

The company has experienced staggering growth, more than doubling its workforce while also achieving over 100% revenue growth year-over-year. The engineering and product teams at EvenUp have developed over 50 releases this year alone, demonstrating their commitment to innovation and responsiveness to client needs.

Testimonials from Industry Figures

Industry leaders like Aaref Hilaly from Bain Capital Ventures highlighted EvenUp as a model for how generative AI can transform real-world challenges within the legal industry. The reception of their tools has exceeded expectations, marking EvenUp as a trailblazer in legal technology.

About EvenUp

EvenUp's mission revolves around leveling the playing field in personal injury cases through advanced machine learning techniques. Their platform is recognized for merging human legal expertise with cutting-edge AI to optimize case management and outcomes. Founded in 2019, EvenUp is rapidly establishing itself as a crucial partner for personal injury law firms across the U.S.

Frequently Asked Questions

What is EvenUp's primary focus?

EvenUp focuses on leveraging AI technology to improve case management and settlement processes in personal injury law.

How much funding did EvenUp recently secure?

EvenUp raised $135 million in its latest Series D funding round, aiming to expand its AI products and services.

What products does EvenUp offer?

The company offers a variety of tools including its Claims Intelligence Platform™, Case Preparation, Negotiation Preparation, Executive Analytics, and more.

How has EvenUp impacted law firms?

EvenUp has helped law firms recover over $1.5 billion in claims and has significantly improved their case preparation process.

What is the expected future of EvenUp?

With its recent funding and robust product offerings, EvenUp is well-positioned for continued growth and to further innovate the legal technology field.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles